Osteopenia Recruiting Phase 1 Trials for Carfilzomib (DB08889)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs